Effectiveness and Safety of Oral Chinese Patent Medicines Combined with Chemotherapy for Gastric Cancer: A Bayesian Network Meta-Analysis

Table 3

Results of the network meta-analysis for leucopenia (upper right quarter) and gastrointestinal reaction (lower left quarter).

BZ + C	3.24 (0.57, 19.51)	0.96 (0.14, 6.41)	1.93 (0.15, 23.60)	1.53 (0.12, 20.54)	1.28 (0.16, 9.39)	0.88 (0.10, 8.09)
0.26 (0.07, 0.83)	C	0.30 (0.13, 0.65)	0.60 (0.09, 3.59)	0.48 (0.07, 3.12)	0.40 (0.13, 1.05)	0.27 (0.07, 1.04)
0.46 (0.12, 1.68)	1.79 (1.17, 2.84)	HCS + C	2.01 (0.26, 15.23)	1.62 (0.23, 13.25)	1.35 (0.36, 4.86)	0.91 (0.20, 4.58)
0.47 (0.11, 1.84)	1.85 (0.94, 3.90)	1.03 (0.44, 2.41)	PX + C	0.81 (0.06, 11.46)	0.67 (0.08, 5.54)	0.46 (0.05, 4.65)
0.40 (0.05, 2.67)	1.52 (0.36, 6.58)	0.85 (0.18, 3.81)	0.83 (0.17, 4.26)	SQSYW + C	0.83 (0.09, 6.08)	0.56 (0.06, 5.76)
0.73 (0.18, 3.04)	2.95 (1.65, 5.88)	1.65 (0.78, 3.58)	1.62 (0.62, 4.28)	1.99 (0.39, 9.86)	XAP + C	0.67 (0.14, 4.16)
0.74 (0.15, 3.08)	2.92 (1.24, 7.06)	1.61 (0.59, 4.34)	1.55 (0.49, 4.87)	1.88 (0.33, 11.05)	1.01 (0.32, 2.87)	ZQFZ + C